Journal Article

Murine Mucopolysaccharidosis Type I: Targeted Disruption of the Murine α-<span class="smallCaps">l</span>-Iduronidase Gene

Lorne A. Clarke, Christopher S. Russell, Scott Pownall, Cara L. Warrington, Anita Borowski, James E. Dimmick, Jennifer Toone and Frank R. Jirik

in Human Molecular Genetics

Volume 6, issue 4, pages 503-511
Published in print April 1997 | ISSN: 0964-6906
Published online April 1997 | e-ISSN: 1460-2083 | DOI:
Murine Mucopolysaccharidosis Type I: Targeted Disruption of the Murine α-l-Iduronidase Gene

Show Summary Details


Mucopolysaccharidosis type I (MPS I) is considered to represent the prototypical mucopolysaccharide storage disorder. Although a spectrum of severity is seen within the MPS I subgroup, Hurler syndrome represents the most severe and frequent manifestation of MPS I. We describe here the generation of a murine model for Hurler syndrome by targeted disruption of the murine Idua gene. Homozygous Idua −/− mice have no detectable α-l-iduronidase enzyme activity and show increased urinary glycosaminoglycan levels. Although normal appearing at birth, Idua −/− mice develop a flattened facial profile and thickening of the digits discernible by 3 weeks of age. No obvious growth deficiency nor mortality is seen within the first 20 weeks of life. Radiographs reveal anterior flaring of the ribs and thickening of the facial bones as early as 4 weeks of age with more extensive dysostosis detectable by 15 weeks of age. At 4 weeks of age, lysosomal storage is noted primarily within reticuloendothelial cells with abundant lysosomes noted in Kupffer cells, splenic sinusoidal lining cells, and glial cells. More widespread lysosomal storage is noted by 8 weeks of age in hepatocytes, chondrocytes, neurons, as well as renal tubular cells. Thus, targeted disruption of the murine Idua locus has produced a murine strain representative of the severe form of MPS I. This model should permit detailed evaluation of the pathophysiology of lysosomal storage disorders and provide a small animal model for the testing and development of enzyme replacement and gene therapy regimes.

Journal Article.  5648 words.  Illustrated.

Subjects: Genetics and Genomics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.